Publication | Open Access

Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications

Medicinal ChemistryAldo-keto ReductaseBiochemistryMedicineAldose ReductaseDiabetesNatural SciencesRational Drug DesignPharmacological AgentSelective InhibitorsPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryChronic Diabetic ComplicationsDrug Discovery